212 related articles for article (PubMed ID: 26265780)
1. Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.
Li N; Sando MM; Spiegelman D; Hertzmark E; Liu E; Sando D; Machumi L; Chalamilla G; Fawzi W
J Infect Dis; 2016 Apr; 213(7):1057-64. PubMed ID: 26265780
[TBL] [Abstract][Full Text] [Related]
2. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
Darak S; Darak T; Kulkarni S; Kulkarni V; Parchure R; Hutter I; Janssen F
AIDS Patient Care STDS; 2013 Mar; 27(3):163-70. PubMed ID: 23477457
[TBL] [Abstract][Full Text] [Related]
3. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
Machado ES; Hofer CB; Costa TT; Nogueira SA; Oliveira RH; Abreu TF; Evangelista LA; Farias IF; Mercadante RT; Garcia MF; Neves RC; Costa VM; Lambert JS
Sex Transm Infect; 2009 Apr; 85(2):82-7. PubMed ID: 18987014
[TBL] [Abstract][Full Text] [Related]
6. No relation between in-utero exposure to HAART and intrauterine growth retardation.
Briand N; Mandelbrot L; Le Chenadec J; Tubiana R; Teglas JP; Faye A; Dollfus C; Rouzioux C; Blanche S; Warszawski J;
AIDS; 2009 Jun; 23(10):1235-43. PubMed ID: 19424054
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
10. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
11. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Short CE; Douglas M; Smith JH; Taylor GP
HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
13. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
Martin F; Taylor GP
J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
[TBL] [Abstract][Full Text] [Related]
14. Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.
Snijdewind IJM; Smit C; Godfried MH; Bakker R; Nellen JFJB; Jaddoe VWV; van Leeuwen E; Reiss P; Steegers EAP; van der Ende ME
PLoS One; 2018; 13(1):e0191389. PubMed ID: 29351561
[TBL] [Abstract][Full Text] [Related]
15. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room?
Mofenson LM
J Infect Dis; 2016 Apr; 213(7):1051-4. PubMed ID: 26265779
[No Abstract] [Full Text] [Related]
17. Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy.
Dola CP; Khan R; DeNicola N; Amirgholami M; Benjamin T; Bhuiyan A; Longo S
J Perinat Med; 2011 Nov; 40(1):51-5. PubMed ID: 22044007
[TBL] [Abstract][Full Text] [Related]
18. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
19. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
[TBL] [Abstract][Full Text] [Related]
20. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
